The equine TLR4/MD-2 complex mediates recognition of lipopolysaccharide from Rhodobacter sphaeroides as an agonist

Journal of Endotoxin Research

Volumn 13, Issue 4, 2007, Pages 235-242

  Lohmann, Katharina L ^a   Vandenplas, Michel L ^a   Barton, Michelle H ^a   Bryant, Clare E ^b   Moore, James N ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Endotoxin antagonist; Equine; Lipopolysaccharide receptor; NF B activation; Transfection

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN MD 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CELL ACTIVATION; CELL STRAIN HEK293; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC TRANSFECTION; HORSE; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RHODOBACTER SPHAEROIDES;

ANIMALS; ANTIGENS, CD14; CELL LINE; HORSES; HUMANS; LIPOPOLYSACCHARIDES; MICROTUBULE-ASSOCIATED PROTEINS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODOBACTER SPHAEROIDES; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTORS; TRANSFECTION;

EQUIDAE; ESCHERICHIA COLI; RHODOBACTER SPHAEROIDES;

EID: 35448968699     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/0968051907083193     Document Type: Article

References (29)

1. Barton MH, Collatos C. Tumor necrosis factor and interleukin-6 activity and endotoxin concentration in peritoneal fluid and blood of horses with acute abdominal disease. J Vet Intern Med 1999; 13: 457-464.
2. Steverink Pjgms, Sturk A., Rutten Vpmg et al. Endotoxin, interleukin-6 and tumor necrosis factor concentrations in equine acute abdominal disease: Relation to clinical outcome. J Endotoxin Res 1995; 2: 289-299.
3. Barton MH, Morris DD, Norton N., Prasse KW Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia. J Vet Intern Med 1998; 12: 26-35.
4. Golenbock DT, Hampton RY, Qureshi N., Takayama K., Raetz CR Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991; 266: 19490-19498.
5. Zuckerman SH, Qureshi N. In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction. Infect Immun 1992; 60: 2581-2587.
6. Qureshi N., Hofmann J., Takayama K., Vogel SN, Morrison DC Diphosphoryl lipid A from Rhodobacter sphaeroides: A novel lipopolysaccharide antagonist. In: Morrison DC, Ryan JL. (eds) Novel therapeutic strategies in the treatment of sepsis. New York: Marcel Dekker, 1996; 111-131.
7. Kovach NL, Yee E., Munford RS, Raetz CR, Harlan JM Lipid IVa inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J Exp Med 1990; 172: 77-84.
8. Delude RL, Savedra Jr R., Zhao H. et al. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc Natl Acad Sci USA 1995; 92: 9288-9292.
9. Aida Y., Kusumoto K., Nakatomi K., Takada H., Pabst MJ, Maeda K. An analogue of lipid A and LPS from Rhodobacter sphaeroides inhibits neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma. J Leukoc Biol 1995; 58: 675-682.
10. Qureshi N., Takayama K., Kurtz R. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect Immun 1991; 59: 441-444.
11. Strittmatter W., Weckesser J., Salimath PV, Galanos C. Nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides ATCC 17023. J Bacteriol 1983; 155: 153-158.
12. Lien E., Means TK, Heine H. et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000; 105: 497-504.
13. Poltorak A., Ricciardi-Castagnoli P., Citterio S., Beutler B. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc Natl Acad Sci USA 2000; 97: 2163-2167.
14. Akashi S., Nagai Y., Ogata H. et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol 2001; 13: 1595-1599.
15. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 2002; 3: 354-359.
16. Muroi M., Ohnishi T., Tanamoto K. MD-2, a novel accessory molecule, is involved in species-specific actions of Salmonella lipid A. Infect Immun 2002; 70: 3546-3550.
17. Lohmann KL, Vandenplas M., Barton MH, Moore JN Lipopolysaccharide from Rhodobacter sphaeroides is an agonist in equine cells. J Endotoxin Res 2003; 9: 33-37.
18. Mizushima S., Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 1990; 18: 5322.
19. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689-10692.
20. Beutler B. TLR4 as the mammalian endotoxin sensor. Curr Top Microbiol Immunol 2002; 270: 109-120.
21. Qureshi N., Takayama K., Hofmann J., Zuckerman SH Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodobacter sphaeroides is an LPS antagonist and an inducer of corticosteroids. In: Levin J, Alving RS, Munford PL. (eds) Bacterial endotoxin: Recognition and effector mechanisms. Amsterdam: Elsevier, 1993; 361-371.
22. Kitchens RL Role of CD14 in cellular recognition of bacterial lipopolysaccharides. In: Jack RS. (ed) CD14 in the inflammatory response. Basel: Karger, 2000; 61-82.
23. Kirkland TN, Finley F., Leturcq D. et al. Analysis of lipopolysaccharide binding by CD14. J Biol Chem 1993; 268: 24818-24823.
24. Ulmer AJ, El-Samalouti VT, Rietschel ET, Flad HD, Dziarski R. CD14, and innate immune receptor for various bacterial cell wall components. In: Brade H, Opal SM, Vogel SN, Morrison DC. (eds) Endotoxin in Health and Disease. Basel: Marcel Dekker, 1999; 463-471.
25. Frey EA, Miller DS, Jahr TG et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992; 176: 1665-1671.
26. Shimazu R., Akashi S., Ogata H. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189: 1777-1782.
27. Takeuchi O., Hoshino K., Kawai T. et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999; 11: 443-451.
28. Visintin A., Mazzoni A., Spitzer JA, Segal DM Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci USA 2001; 98: 12156-12161.
29. Kawasaki K., Akashi S., Shimazu R., Yoshida T, Miyake K, Nishijima M. Mouse Toll-like receptor 4·MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J Biol Chem 2000; 275: 2251-2254.